Dr. Jake Everett Turrentine, MD

Dr. Turrentine practices at Skin Surgery Center PA in Winston Salem, North Carolina.

Dr. Turrentine's NPI, 1386934933, was assigned on April 17, 2011. Dr. Turrentine holds North Carolina license 2016-02183.

Dr. Turrentine's primary practice is Skin Surgery Center PA, at 1450 Professional Park Dr, Winston Salem, NC 27103 in Forsyth County. The practice phone is (336) 724-2434.

Dr. Turrentine's primary practice is Skin Surgery Center PA in Winston Salem, North Carolina. Dr. Turrentine is also affiliated with UNC Health Blue Ridge. The medical group on file is The Skin Surgery Center. Dmand AI also links Dr. Turrentine to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Turrentine practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Turrentine's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dmand AI has Dr. Turrentine's licenses on file in 5 states: North Carolina, Florida, Georgia, South Carolina and Texas.

CMS data shows 20,088 Medicare services from Dr. Turrentine across 33 procedure codes in 2024, for 1,249 Medicare patients. Medicare paid $1,006,892 for them. Every service was in an office.

CMS counts 1,249 Medicare patients who saw Dr. Turrentine in 2024. The largest group is 65 to 74, with 565 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 3% are also on Medicaid. Their average risk score is 1.04, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Turrentine's median patient age at 74, with 51% women.

In 2024, Dr. Turrentine wrote 1,835 Medicare Part D claims for 696 patients. 90% of them were for generic drugs. CMS names the drug for 1,629 of them, across 35 drugs with 11 or more claims each, at $914,261 in total drug cost. In 2023, CMS named 1,762 claims across 33 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Turrentine for performance year 2024, reported as part of a group. Dr. Turrentine accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 405 procedures of melanoma (skin cancer) excision by Dr. Turrentine, more than 99% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 21 papers to Dr. Turrentine, published from 2014 to 2023. 2014 was the busiest year, with 3. The most frequent topics are Skin Neoplasms, Administration, Cutaneous and Amitriptyline. Dr. Turrentine has published most often in Dermatitis. Dr. Turrentine's most frequent co-authors are Ponciano D. Cruz, MD, Nnenna Gebechi Agim, MD and Abigail Elizabeth Cline, MD.

CMS Open Payments shows 193 general payments to Dr. Turrentine from 16 drug and device companies from 2018 to 2025. Speaker and faculty fees make up the largest share, 82% of the total. Sun Pharmaceutical Industries Inc. paid the most, $112,942. It also lists 1 research payment totaling $3,061 in 2025.